Paper27600596
The dopamine D3 receptor, a quarter century later.
Sokoloff P and 1 other. Eur J Neurosci, 2017. Cited by 190 papers, by iCite.
Cite this record
ConductScience Library. The dopamine D3 receptor, a quarter century later. Papers, record 27600596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27600596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Dopamine Antagonists | Major topic |
| Drug-Seeking Behavior | Major topic |
| Receptors, Dopamine D3 | Major topic |
| Substance-Related Disorders | Major topic |
| Animals | |
| Humans | |
| Receptors, Dopamine D2 |
Source PubMed
Cited by125
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 190 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42638752 | Pramipexole treatment and substance use disorder risk in unipolar and bipolar depression: a Swedish nationwide register study. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42638752 | PubMed |
| 42516875 | Dopamine D3 receptor blockade restores hippocampal synaptic plasticity and rescues memory deficits in Alzheimer's disease mouse models. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42516875 | PubMed |
| 42356545 | From Antipsychotic to Antitumor Agent: Cariprazine Suppresses Glioblastoma via D2/D3-ARRB2 Axis Modulation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356545 | PubMed |
| 42274167 | Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity. | J Dual Diagn | 2026 | https://conductscience.org/library/papers/42274167 | PubMed |
| 42146536 | D3 dopamine receptors implicate a striatal neuronal subtype in the aversive effects of the antipsychotic drug quetiapine. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146536 | PubMed |
| 41651017 | Impact of environmental enrichment on heroin-induced neuroadaptations in the insula, nucleus accumbens and ventral tegmental area. | Neuropharmacology | 2026 | https://conductscience.org/library/papers/41651017 | PubMed |
| 41275753 | Increased social reward behavior in adolescent male and female rats exposed prenatally to alcohol is associated with altered dopamine receptor expression. | Psychoneuroendocrinology | 2026 | https://conductscience.org/library/papers/41275753 | PubMed |
| 41191868 | Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis. | Int Clin Psychopharmacol | 2026 | https://conductscience.org/library/papers/41191868 | PubMed |
| 40904619 | Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder. | Clinicoecon Outcomes Res | 2025 | https://conductscience.org/library/papers/40904619 | PubMed |
| 40800788 | Molecular connectivity studies in neurotransmission: a scoping review. | Imaging Neurosci (Camb) | 2025 | https://conductscience.org/library/papers/40800788 | PubMed |
| 40748686 | Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D3 Dopamine Receptor. | J Med Chem | 2025 | https://conductscience.org/library/papers/40748686 | PubMed |
| 40650296 | Blockade of Dopamine D3 Receptors in the Ventral Tegmental Area Mitigates Fear Memory Generalization. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650296 | PubMed |
| 40529937 | Higher levels of D2R and D3R in the frontal-striatal regions are associated with reduced perseverative reward seeking after opioid abstinence. | Front Behav Neurosci | 2025 | https://conductscience.org/library/papers/40529937 | PubMed |
| 40290808 | A nanoluciferase complementation-based assay for monitoring β-arrestin2 recruitment to the dopamine D3 receptor. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40290808 | PubMed |
| 40161932 | Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia. | Bioimpacts | 2025 | https://conductscience.org/library/papers/40161932 | PubMed |
| 40123860 | Effect of cariprazine on attention and quality of life in patients with predominant negative symptoms of schizophrenia: A post-hoc analysis. | Schizophr Res Cogn | 2025 | https://conductscience.org/library/papers/40123860 | PubMed |
| 39857669 | Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds. | Biomedicines | 2025 | https://conductscience.org/library/papers/39857669 | PubMed |
| 39587339 | Microviridae bacteriophages influence behavioural hallmarks of food addiction via tryptophan and tyrosine signalling pathways. | Nat Metab | 2024 | https://conductscience.org/library/papers/39587339 | PubMed |
| 39520655 | Effect of Cariprazine on Anhedonia in Patients with Bipolar I Depression: Post Hoc Analysis of Three Randomized Placebo-Controlled Clinical Trials. | Adv Ther | 2025 | https://conductscience.org/library/papers/39520655 | PubMed |
| 39236310 | Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age-related cognitive phenotype. | Aging Cell | 2024 | https://conductscience.org/library/papers/39236310 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27600596
GET https://conductscience.org/api/papers/v1/27600596/cited_by?page=2